SII seeks govt's nod to manufacture, stockpile qHPV vaccine against cervical cancer

The Serum Institute of India has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer after the completion of the phase 2/3 clinical trials to ensure its early availability in the country, official sources said

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bF7xJWs
via IFTTT